Target Name: TRNS2
NCBI ID: G4575
Review Report on TRNS2 Target / Biomarker Content of Review Report on TRNS2 Target / Biomarker
TRNS2
Other Name(s): MTTS2 | tRNA Ser2 (AGU/C) | MT-TS2 | Mitochondrially encoded tRNA serine 2 (AGU/C) | mitochondrially encoded tRNA-Ser (AGU/C) 2 | mitochondrially encoded tRNA serine 2 (AGU/C)

TRNS2: A Protein Involved in Many Physiological Processes

TRNS2 (Transient receptor potential cation channel subfamily 2) is a protein that is expressed in many different tissues and cells in the body. It is a member of the TRP family of cation channels, which are involved in the regulation of ion channels and are found in many different organisms, including humans. TRNS2 is involved in the regulation of a variety of physiological processes in the body, including neuronal signaling, muscle contractions, and the regulation of ion channels in the heart.

One of the key functions of TRNS2 is its role in the regulation of action potentials, which are the electrical signals that are generated by the entry of ions into the cell. In neurons, action potentials are generated by the arrival of positive ions at the expense of negative ions, which results in a change in the electrical potential across the cell membrane. TRNS2 is involved in the regulation of the height and duration of action potentials, as well as the regulation of the release of ions from the cell.

In addition to its role in the regulation of action potentials, TRNS2 is also involved in the regulation of muscle contractions. Muscle contractions are generated by the activation of muscle fibers, which results in the rapid and powerful contraction of the muscle. TRNS2 is involved in the regulation of the contraction and relaxation of muscle fibers, as well as the regulation of the growth and maintenance of muscle fibers.

TRNS2 is also involved in the regulation of the regulation of ion channels in the heart. The heart is a highly specialized muscle that is responsible for pumping blood throughout the body. TRNS2 is involved in the regulation of the ion channels in the heart, which are responsible for the entry and exit of ions into the cell. This regulation is critical for the proper functioning of the heart and is a target for a variety of drugs, including diuretics, which are used to remove excess fluid from the body.

In addition to its roles in the regulation of action potentials, muscle contractions, and ion channels, TRNS2 is also involved in the regulation of a variety of other physiological processes in the body. For example, it is involved in the regulation of the production and release of hormones, such as testosterone and estrogen, which are responsible for the development and maintenance of secondary sexual characteristics in males and females. TRNS2 is also involved in the regulation of the production and release of insulin, which is responsible for regulating blood sugar levels.

Overall, TRNS2 is a highly versatile protein that is involved in a wide range of physiological processes in the body. Its role in the regulation of action potentials, muscle contractions, and ion channels is critical for the proper functioning of many different tissues and organs in the body. As a drug target and biomarker, TRNS2 is a promising target for the development of new treatments for a variety of diseases.

Protein Name: Mitochondrially Encoded TRNA Serine 2 (AGU/C)

The "TRNS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRNS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TRNT | TRNT1 | TRNV | TRNW | TRNY | TRO | TROAP | TROAP-AS1 | Troponin | TRP-AGG2-5 | TRP-AGG6-1 | TRPA1 | TRPC1 | TRPC2 | TRPC3 | TRPC4 | TRPC4AP | TRPC5 | TRPC6 | TRPC7 | TRPC7-AS1 | TRPM1 | TRPM2 | TRPM2-AS | TRPM3 | TRPM4 | TRPM5 | TRPM6 | TRPM7 | TRPM8 | TRPS1 | TRPT1 | TRPV1 | TRPV2 | TRPV3 | TRPV4 | TRPV5 | TRPV6 | TRR-ACG1-2 | TRRAP | TRU-TCA2-1 | TRUB1 | TRUB2 | Trypanosome lytic factor 1 | Trypanosome lytic factor 2 | Trypsin | Tryptase | Tryptophan 5-Monooxygenase | TSACC | TSBP1 | TSBP1-AS1 | TSC1 | TSC2 | TSC22D1 | TSC22D1-AS1 | TSC22D2 | TSC22D3 | TSC22D4 | TSEN15 | TSEN2 | TSEN2P1 | TSEN34 | TSEN54 | TSFM | TSG1 | TSG101 | TSGA10 | TSGA10IP | TSGA13 | TSHB | TSHR | TSHZ1 | TSHZ2 | TSHZ3 | TSHZ3-AS1 | TSIX | TSKS | TSKU | TSLP | TSN | TSNARE1 | TSNAX | TSNAX-DISC1 | TSNAXIP1 | TSPAN1 | TSPAN10 | TSPAN11 | TSPAN12 | TSPAN13 | TSPAN14 | TSPAN15 | TSPAN16 | TSPAN17 | TSPAN18 | TSPAN19 | TSPAN2 | TSPAN3 | TSPAN31 | TSPAN32 | TSPAN33